Harvest Fund Management Co., LTD Gilead Sciences, Inc. Transaction History
Harvest Fund Management Co., LTD
- $1.98 Billion
- Q1 2025
A detailed history of Harvest Fund Management Co., LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 97,254 shares of GILD stock, worth $10.6 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
97,254
Previous 80,889
20.23%
Holding current value
$10.6 Million
Previous $7.47 Million
45.86%
% of portfolio
0.55%
Previous 0.35%
Shares
21 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.49 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.96 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.84 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...